Lonza Group AG LONN.SW

CH · SIX Swiss Exchange · XSWX · stock · Healthcare · website

Lonza Group AG financials (annual)

Revenue

Net income

Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).

Metric	FY2025	FY2024	FY2023	FY2022
Revenue	CHF 6.5B	CHF 5.5B	CHF 6.7B	CHF 6.2B
Gross profit	CHF 2.3B	CHF 1.8B	CHF 1.9B	CHF 2.4B
R&D expense	CHF 112.0M	CHF 102.0M	CHF 105.0M	CHF 95.0M
SG&A expense	CHF 765.0M	CHF 712.0M	CHF 837.0M	CHF 827.0M
Operating income	CHF 1.4B	CHF 879.0M	CHF 873.0M	CHF 1.4B
Interest expense	CHF 163.0M	CHF 140.0M	CHF 93.0M	CHF 63.0M
Income tax	CHF 192.0M	CHF 106.0M	CHF 135.0M	CHF 230.0M
Net income	-CHF 275.0M	CHF 636.0M	CHF 654.0M	CHF 1.2B
EPS (diluted)	CHF -3.93	CHF 8.92	CHF 8.88	CHF 16.34
Operating cash flow	CHF 1.2B	CHF 1.3B	CHF 1.4B	CHF 1.0B
Free cash flow	-CHF 217.0M	-CHF 143.0M	-CHF 294.0M	-CHF 852.0M
Cash & equivalents	CHF 719.0M	CHF 1.1B	CHF 1.5B	CHF 1.3B
Inventory	CHF 1.7B	CHF 1.7B	CHF 1.6B	CHF 1.8B
Goodwill	CHF 2.0B	CHF 3.4B	CHF 2.8B	CHF 2.9B
Total assets	CHF 17.9B	CHF 19.7B	CHF 16.8B	CHF 17.4B
Total debt	CHF 4.5B	CHF 5.1B	CHF 3.1B	CHF 2.6B
Total liabilities	CHF 9.9B	CHF 10.3B	CHF 7.3B	CHF 6.7B
Shareholders' equity	CHF 7.9B	CHF 9.3B	CHF 9.5B	CHF 10.6B
Share buybacks	CHF 518.0M	CHF 769.0M	CHF 1.2B	CHF 58.0M

Growth · year-over-year · Revenue CAGR 1.6%

Metric	FY2025	FY2024	FY2023	FY2022
Revenue growth	+19.2%	-18.4%	+7.9%	—
Net income growth	-143.2%	-2.8%	-46.2%	—
EPS growth	-144.1%	+0.5%	-45.7%	—

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · CH · as of 2025-12-31. Figures in CHF. Facts plus Stocktoria's own computed scores — not investment advice.